BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 580588)

  • 1. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)].
    Klein WW; Pavek P
    Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of meproscillarin on left ventricular hemodynamics (author's transl)].
    Pachinger O; Probst P
    Arzneimittelforschung; 1978; 28(3a):550-2. PubMed ID: 580587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
    Pozenel H
    Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the disposition of meproscillarin in rat and dog (author's transl)].
    Weymann J; Schenk G; Kesselring K
    Arzneimittelforschung; 1978; 28(3a):520-6. PubMed ID: 580582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)].
    Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I
    Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)].
    Eckardt A; Koch W; Safer A
    Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of meproscillarin in man (author's transl)].
    Rietbrock N
    Arzneimittelforschung; 1978; 28(3a):540-5. PubMed ID: 580585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elimination of meproscillarin by hemoperfusion (author's transl)].
    Rupp M; Brass H; Belz GG
    Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Labelling meproscillarin with tritium at the C-19 position (author's transl)].
    Schenk G; Albrecht HP; Lietz H
    Arzneimittelforschung; 1978; 28(3a):518-9. PubMed ID: 580581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose].
    Herken H; Brandes J
    Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)].
    Kubinyi H
    Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the development of an oral preparation of meproscillarin (author's transl)].
    Einig H; Mayer D
    Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative hemodynamic studies on various heart glycosides].
    Gotsch K; Klein WW; Leb G; Pavek P; Passath A
    Z Kreislaufforsch; 1972 Jul; 61(7):577-87. PubMed ID: 5055577
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy.
    Bonelli J; Magometschnig D; Gazo F
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):243-5. PubMed ID: 3410600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative measurement of pulmonary artery pressure after meproscillarin and beta-methyldigoxin demonstrating their effects on the left bentricular function in patients with heart and coronary insufficiency].
    Stauch M; Nissen N; Grewe N
    Arzneimittelforschung; 1978; 28(3a):545-50. PubMed ID: 580586
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.